Search results

193 items
  1. Cannabis Regulation in Europe

    30 March 2019
    Snapshot

    Local and regional authorities across Europe are confronted with the negative consequences of a persisting illicit cannabis market. Increasingly, local and regional authorities, non-governmental pressure groups and grassroots movements are advocating a regulation of the recreational cannabis market.

  2. Online course “Drugs, drug use, drug policy and health”

    10 July 2018
    Article

    What are drugs and why are they controlled? What are the benefits and harms of taking drugs? How public health policies can address drug use? Learn the answers to these questions and more in the free online course 'Drugs, drug use, drug policy and health'.

  3. Cannabis in the City: Developments in local cannabis regulation in Europe

    • Tom Blickman, Katie Sandwell, Dania Putri, Xabier Arana, Tom Decorte, Vibeke Asmussen Frank, Dirk J. Korf, Ingo Ilja Michels, Maj Nygaard-Christensen, Tim Pfeiffer-Gerschel, Heino Stöver, Bernd Werse, Frank Zobel
    20 March 2019
    Report

    In order to better understand the situation around, and possibilities for, local and regional cannabis regulation, a series of six country reports were developed. The country reports provide detailed information about the state of cannabis policy, and the possibilities for change, within each country. This Report summarises some of the key findings from the research and explores opportunities, obstacles, and strategies for cannabis regulation at the municipal and regional level.

  4. Women and drugs in Myanmar: Beyond harm reduction

    Dania Putri
    08 March 2018
    Article

    In Myanmar’s Kachin State, a women’s drop-in centre has transformed into more than just a harm reduction facility. Leading up to International Women’s Day, we spoke with Thinzar Tun (AHRN Myanmar) about what makes this centre special.

  5. The 9th Asian Informal Drug Policy Dialogue

    31 May 2018
    Report

    In December 2017, the Transnational Institute (TNI) and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), on behalf of the Federal Ministry of Economic Cooperation and Development of Germany (BMZ), in collaboration with the Thai Office of the Narcotics Control Board (ONCB) and the Mae Fah Luang Foundation under Royal Patronage (MFLF), jointly organised the 9th Asian Informal Drug Policy Dialogue (IDPD) in Chiang Rai, Thailand. 

  6. Urgent Reform Needed

    04 August 2010
    Article

    Experts and policymakers have gathered in Vienna for the 18th International AIDS Conference to evaluate current trends in HIV/AIDS treatment and prevention. Despite the widespread attention given to the subject, countries around the world continue to maintain draconian drug laws that are increasing the spread of the disease. Several leading AIDS, human rights and drug policy reform organisations and leading scientists are calling for urgent action to change current drug laws and incorporate evidence-based approaches to drug and HIV/AIDS treatment and prevention to reverse this trend.

  7. Methamphetamine use in Myanmar, Thailand, and Southern China: assessing practices, reducing harms

    • Thura Myint Lwin
    18 February 2019
    Policy briefing

    Over the past decade, methamphetamine use has grown more popular in Myanmar, Thailand and Southern China. Based on in-depth interviews conducted with individuals who use methamphetamine, this briefing sheds light on the importance of promoting an environment that reinforces, rather than undermines, the ability of people who use methamphetamine to regulate their drug use, preserve their health and adopt safer practices.

  8. Global State of Harm Reduction

    01 January 2012

    The Global State of Harm Reduction e-tool is an online resource containing up-to-date information on harm reduction policy and programming around the world. The web pages draw on the latest research in this area to present an at-a-glance guide to the current state of harm reduction worldwide.

     

  9. Image of UN Flag

    UNGASS review reaches critical stage

    03 November 2008
    Article

    The review of the objectives and action plans agreed at the 1998 UNGASS on Drugs has reached a critical stage. Following the thematic debate at the 2008 Commission on Narcotic Drugs, and the five expert working groups held in Vienna over the summer, the attention now moves to the political process of negotiating the text of a political declaration to be agreed at the high level meeting in March 2009.

  10. Latin America needs a new drug policy approach

    02 May 2008
    Article

    TNI’s Martin Jelsma participated in the inaugural meeting in Rio de Janeiro of the Latin American Commission on Drugs and Democracy on April 30, 2008. Prominent members of the Commission are three Latin American former presidents: Fernando Henrique Cardoso from Brazil, César Gaviria from Colombia and Ernesto Zedillo from Mexico.

    "It is time to develop a proper Latin American response that is detached from the ideology from the United States that has been common in the past decade," Martin Jelsma told the meeting. "It is potentially a good time to try because politically there is now more distance to US policies in a growing part of Latin America and to US domination in general."

  11. Global State of Harm Reduction 2014

    • International Harm Reduction Association (IHRA)
    04 March 2015
    Report

    In 2008, Harm Reduction International released the Global State of Harm Reduction, a report that mapped responses to drug-related HIV and hepatitis C epidemics around the world for the first time.(1) The data gathered for the report provided a critical baseline against which progress could be measured in terms of the international, regional and national recognition of harm reduction in policy and practice. Since then, the biennial report has become a key publication for researchers, policymakers, civil society organisations and advocates, mapping harm reduction policy adoption and programme implementation globally.

  12. The Global State of Harm Reduction 2010

    01 April 2010

    The report provides a region-by-region update of key developments in harm reduction. It also explores several issues key to the response to drug-related harms worldwide, including increasing access to harm reduction in prisons and other places of detention, reaching people who use drugs with diagnosis, treatment and care for viral hepatitis and tuberculosis, preventing overdose-related mortality among people who use drugs, preventing and treating injecting-related bacterial infections, expanding the response to harms related to amphetamine use and addressing the current shortage of funds for harm reduction worldwide.

     

  13. Costa in Amsterdam

    Tom Blickman
    02 June 2008
    Article

    The head of the UN Office on Drugs and Crime (UNODC), Antonio Costa, recently visited Amsterdam on 24 April. Accompanied by some officials of the Netherlands Ministry of Health and of the City of Amsterdam and UNODC staff, he dropped in on the coffeeshop De Dampkring (the Atmosphere) and a user room (for inhalation and injection of heroin and cocaine). He wrote his personal account for his blog Costa’s corner but it was never published. Apparently it proved to be too controversial with his Dutch host. It now has popped up on the Transform drug policy blog and the ENCOD website.

  14. Policy Reform Needed to Stem Burma’s Resurgent Drug Trade

    02 June 2014
    In the media

    The resurgence of the illicit drugs trade in Burma in recent years is the result of flawed drug control policies by Burma and its neighbors, a new report says. It urges regional governments to reform their repressive policies in order to better address the trade’s underlying causes, such as rural poverty, and the impact of a rise in drug use.

  15. Cannabis debate in Australia

    Tom Blickman
    04 June 2008
    Article

    In Australia a vicious debate on cannabis policy started when Alex Wodak, the head of the Sydney drug and alcohol clinic at St Vincent's Hospital, suggested that marijuana be regulated like alcohol or tobacco. He proposed to sell cannabis legally in post offices in packets that warn against its effects.

  16. The current state of drug policy debate

    • Martin Jelsma
    30 April 2008

    Martin Jelsma, from the Transnational Institute, prepared an analysis for the Latin American Commission on Drugs and Democracy, explaining the drug policy situation in the European Union and the current state of debate in the United Nations agenda. The commission is an initiative born of former presidents Fernando Henrique Cardoso, from Brazil, César Gaviria, from Colombia and Ernesto Zedillo, from Mexico, to respond to concerns related to the problems of drug consumption and traffic in Latin America. The idea to constitute a commission capable of consolidating a debate concerning this problematic also responds to the necessity of reviewing the world drug policies in the scope of the United Nations, which began in March 2008.

  17. The current state of drug policy debate

    09 June 2008
    Article

    Martin Jelsma, from the Transnational Institute, prepared an analysis for the Latin American Commission on Drugs and Democracy, explaining the drug policy situation in the European Union and the current state of debate in the United Nations agenda. The commission is an initiative born of former presidents Fernando Henrique Cardoso, from Brazil, César Gaviria, from Colombia and Ernesto Zedillo, from Mexico, to respond to concerns related to the problems of drug consumption and traffic in Latin America. The idea to constitute a commission capable of consolidating a debate concerning this problematic also responds to the necessity of reviewing the world drug policies in the scope of the United Nations, which began in March 2008.

  18. publication

    Use of Narcotic Drugs in Public Injection Rooms under Public International Law

    07 January 2000

    State-controlled public injection rooms are not expressly referred to in any of the rele­vant international conventions. It is thus necessary to determine, by way of a prelimi­nary factual enquiry, the exact characteristics of such institutions that fall within the ambit of one or more of the conventions. The rather superficial provisions concerning drug addicts stand in stark contrast to the stated primary aims of the conventions, which are formulated in the preambles as pre­venting and combatting abuse of narcotic drugs and psychotropic substances and the public health and social problems which such abuse engenders.

  19. Thumbnail

    Recent developments regarding drug law and policy in Germany and the European Community

    • Lorenz Böllinger
    21 March 2002

    publicationRecent developments in drug policy can be regarded as taking place in stages based on certain changeable paradigms: the abstinence paradigm, the medicalization paradigm and the acceptance paradigm. For the time being there seems to be a slow transition from the first to the latter, implying that elements of all three are presently active in a diversity of policies and strategies, differing between states and regions of the German federal state and the European Union as well as between different levels of drug policy and drug care.

    application-pdfDownload the document (PDF)

  20. Effect of Drug Law Enforcement on Drug-Related Violence

    • Dan Werb, Greg Rowell, Gordon Guyatt, Thomas Kerr, Julio Montaner, Evan Wood
    01 April 2010

    This report consists of a scientific review that illustrates the relationship between drug law enforcement and drug-related violence. Violence is among the primary concerns of communities around the world, and research from many settings has demonstrated clear links between violence and the illicit drug trade, particularly in urban settings. While violence has traditionally been framed as resulting from the effects of drugs on individual users (e.g., drug-induced psychosis), violence in drug markets and in drug-producing areas such as Mexico is increasingly understood as a means for drug gangs to gain or maintain a share of the lucrative illicit drug market.

     

Pages